Absci (ABSI) Cash & Current Investments (2020 - 2026)

Absci's (ABSI) quarterly Cash & Current Investments came in at $125.7 million in Q1 2026, down 6.18% year-on-year from $134.0 million in Q1 2025, and down 12.88% quarter-over-quarter from $144.3 million in Q4 2025.

Absci (ABSI) Cash & Current Investments (2020 - 2026) Analysis & Trends

Absci has disclosed Cash & Current Investments across 7 years of filings, most recently posting $125.7 million for Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $125.7 million, down 6.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.7 million (down 6.18% YoY), and the FY2025 annual result was $144.3 million, up 28.35% from the prior year.
  • Cash & Current Investments came in at $125.7 million for Q1 2026 at Absci, down from $144.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $226.0 million in Q1 2022 to a low of $97.7 million in Q4 2023.
  • The 5-year median for Cash & Current Investments is $134.0 million (2025), against an average of $141.3 million.
  • Peak annual rise in Cash & Current Investments reached 107.16% in 2022, while the deepest fall reached 62.28% in 2022.
  • Absci's Cash & Current Investments stood at $164.4 million in 2022, then plunged by 40.61% to $97.7 million in 2023, then advanced by 15.12% to $112.4 million in 2024, then rose by 28.35% to $144.3 million in 2025, then decreased by 12.88% to $125.7 million in 2026.
  • The last three Cash & Current Investments figures came in at $125.7 million (Q1 2026), $144.3 million (Q4 2025), and $152.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Absci 1.13 Bn 1.01 Bn - 125.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 125.71 Mn
Dec 31, 2025 144.29 Mn
Sep 30, 2025 152.48 Mn
Jun 30, 2025 117.46 Mn
Mar 31, 2025 133.98 Mn
Dec 31, 2024 112.43 Mn
Sep 30, 2024 127.07 Mn
Jun 30, 2024 145.25 Mn
Mar 31, 2024 161.54 Mn
Dec 31, 2023 97.66 Mn
Sep 30, 2023 113.48 Mn
Jun 30, 2023 124.59 Mn
Mar 31, 2023 144.26 Mn
Dec 31, 2022 164.43 Mn
Sep 30, 2022 105.35 Mn
Jun 30, 2022 206.02 Mn
Mar 31, 2022 226.00 Mn
Dec 31, 2021 252.57 Mn
Sep 30, 2021 279.26 Mn
Jun 30, 2021 99.45 Mn